Mobile Health Technologies in Cardiopulmonary Disease

Grant E MacKinnon, Evan L Brittain, Grant E MacKinnon, Evan L Brittain

Abstract

Mobile health (mHealth) technologies are modernizing medicine by affording greater patient engagement, monitoring, outreach, and health-care delivery. The cardiopulmonary fields have led the integration of mHealth into clinical practice and research. mHealth technologies in these areas include smartphone applications, wearable devices, and handheld devices, among others, and provide real-time monitoring of numerous important physiological measurements and other key parameters. Use of mHealth-compatible devices has increased in recent years, and age and socioeconomic gaps of ownership are narrowing. These tools provide physicians and researchers with a better understanding of an individual's health and well-being. mHealth interventions have shown utility in the prevention, monitoring, and management of atrial fibrillation, heart failure, and myocardial infarction. With the growing prevalence of cardiopulmonary disease, mHealth technologies may become a more essential element of care within and outside of traditional health-care settings. mHealth is continuously developing as a result of technologic advancements and better understandings of mHealth utility. However, there is little regulation on the mHealth platforms available for commercial use and even fewer guidelines on implementing evidence-based practices into mHealth technologies. Online security is another challenge and necessitates development in data collection infrastructure to manage the extraordinary volume of patient data. Continued research on long-term implications of mHealth technology and the integration of effective interventions into clinical practice is required.

Keywords: cardiovascular disease; digital health; mHealth; mobile health.

Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Potential mobile health applications in various stages of cardiovascular health-care delivery. CVD = cardiovascular disease; CVRF = cardiovascular risk factor; EHR = electronic health record.

References

    1. Muhlestein D., Saunders R.S., Richards R., McClellan M.B. Recent progress in the value journey: growth of ACOs and value-based payment models in 2018. HealthAffairs website.
    1. Kay M., Santos J., Takane M. New Horizons for Health Through Mobile Technologies. World Health Organization; Geneva, Switzerland: 2011.
    1. Silver L. Smartphone ownership is growing rapidly around the world, but not always equally. Pew Research Center website.
    1. Mhealth apps market size, share & trends analysis report by type (fitness, lifestyle management, nutrition & diet, women's health, medication adherence, healthcare providers/payers), and segment forecasts, 2019 - 2026. Grand View Research website.
    1. Edwards E.A., Lumsden J., Rivas C. Gamification for health promotion: systematic review of behaviour change techniques in smartphone apps. BMJ Open. 2016;6(10)
    1. U.S. Food and Drug Administration Device software functions including mobile medical applications.
    1. Liu S. Owners' daily use of smartwatch functions in the United States in 2017. statista website.
    1. Steinhubl S.R., Muse E.D., Topol E.J. The emerging field of mobile health. Sci Transl Med. 2015;7(283):283rv3.
    1. Lamkin P. Wearable tech market to be worth $34 billion by 2020. Forbes website.
    1. Eapen Z.J., Turakhia M.P., McConnell M.V. Defining a mobile health roadmap for cardiovascular health and disease. J Am Heart Assoc. 2016;5(7) pii: e003119.
    1. Bittel A.J., Elazzazi A., Bittel D.C. Accuracy and precision of an accelerometer-based smartphone app designed to monitor and record angular movement over time. Telemed J E Health. 2016;22(4):302–309.
    1. Maddison R., Pfaeffli L., Whittaker R. A mobile phone intervention increases physical activity in people with cardiovascular disease: results from the heart randomized controlled trial. Eur J Prev Cardiol. 2015;22(6):701–709.
    1. Cadmus-Bertram L.A., Marcus B.H., Patterson R.E., Parker B.A., Morey B.L. Randomized trial of a fitbit-based physical activity intervention for women. Am J Prev Med. 2015;49(3):414–418.
    1. Martin S.S., Feldman D.I., Blumenthal R.S. mActive: a randomized clinical trial of an automated mhealth intervention for physical activity promotion. J Am Heart Assoc. 2015;4(11) pii: e002239.
    1. Harries T., Eslambolchilar P., Rettie R., Stride C., Walton S., van Woerden H.C. Effectiveness of a smartphone app in increasing physical activity amongst male adults: a randomised controlled trial. BMC Public Health. 2016;16:925.
    1. Mascarenhas M.N., Chan J.M., Vittinghoff E., Van Blarigan E.L., Hecht F. Increasing physical activity in mothers using video exercise groups and exercise mobile apps: randomized controlled trial. J Med Internet Res. 2018;20(5):e179.
    1. Silverman-Lloyd L.G., Kianoush S., Blaha M.J., Sabina A.B., Graham G.N., Martin S.S. mActive-Smoke: a prospective observational study using mobile health tools to assess the association of physical activity with smoking urges. JMIR Mhealth Uhealth. 2018;6(5):e121.
    1. Godino J.G., Merchant G., Norman G.J. Using social and mobile tools for weight loss in overweight and obese young adults (project smart): a 2 year, parallel-group, randomised, controlled trial. Lancet Diabetes Endocrinol. 2016;4(9):747–755.
    1. Spring B., Duncan J.M., Janke E.A. Integrating technology into standard weight loss treatment: a randomized controlled trial. JAMA Intern Med. 2013;173(2):105–111.
    1. Spring B., Pellegrini C., McFadden H.G. Multicomponent mhealth intervention for large, sustained change in multiple diet and activity risk behaviors: the make better choices 2 randomized controlled trial. J Med Internet Res. 2018;20(6)
    1. McClure J.B., Heffner J., Hohl S., Klasnja P., Catz S.L. Design considerations for mhealth programs targeting smokers not yet ready to quit: results of a sequential mixed-methods study. JMIR Mhealth Uhealth. 2017;5(3):e31.
    1. Bricker J.B., Mull K.E., Kientz J.A. Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. Drug Alcohol Depend. 2014;143:87–94.
    1. Cobos-Campos R.L., Fernández de Larrinoa A.A., Moriñigo A.S., Diez N.P., Barandiaran F.A. Effectiveness of text messaging as an adjuvant to health advice in smoking cessation programs in primary care: a randomized clinical trial. Nicotine Tob Res. 2017;19(8):901–907.
    1. McManus R.J., Mant J., Haque M.S. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808.
    1. Varleta P., Acevedo M., Akel C. Mobile phone text messaging improves antihypertensive drug adherence in the community. J Clin Hypertens (Greenwich) 2017;19(12):1276–1284.
    1. Kim J.Y., Wineinger N.E., Steinhubl S.R. The influence of wireless self-monitoring program on the relationship between patient activation and health behaviors, medication adherence, and blood pressure levels in hypertensive patients: a substudy of a randomized controlled trial. J Med Internet Res. 2016;18(6):e116.
    1. Osterberg L., Raja P., Cruz M. First clinical evaluation of a digital health offering to optimize treating in patients with uncontrolled hypertension and type 2 diabetes. J Am Coll Cardiol. 2016;67(13):2028.
    1. Klonoff D.C. The current status of mhealth for diabetes: Will it be the next big thing? J Diabetes Sci Technol. 2013;7(3):749–758.
    1. Quinn C.C., Shardell M.D., Terrin M.L. Mobile diabetes intervention for glycemic control in 45- to 64-year-old persons with type 2 diabetes. J Appl Gerontol. 2016;35(2):227–243.
    1. Wayne N., Perez D.F., Kaplan D.M., Ritvo P. Health coaching reduces hba1c in type 2 diabetic patients from a lower-socioeconomic status community: a randomized controlled trial. J Med Internet Res. 2015;17(10):e224.
    1. Baron J.S., Hirani S., Newman S.P. A randomised, controlled trial of the effects of a mobile telehealth intervention on clinical and patient-reported outcomes in people with poorly controlled diabetes. J Telemed Telecare. 2017;23(2):207–216.
    1. Singh S.P., Mukherjee S., Galindo L.H. Evaluation of accuracy dependence of raman spectroscopic models on the ratio of calibration and validation points for non-invasive glucose sensing. Anal Bioanal Chem. 2018;410(25):6469–6475.
    1. Turakhia M.P., Shafrin J., Bognar K. Estimated prevalence of undiagnosed atrial fibrillation in the united states. PLoS One. 2018;13(4)
    1. Reiffel J.A., Verma A., Kowey P.R. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the reveal AF study. JAMA Cardiol. 2017;2(10):1120–1127.
    1. Gussak I., Vukajlovic D., Vukcevic V. Wireless remote monitoring of reconstructed 12-lead ecgs after ablation for atrial fibrillation using a hand-held device. J Electrocardiol. 2012;45(2):129–135.
    1. Castaneda D., Esparza A., Ghamari M., Soltanpur C., Nazeran H. A review on wearable photoplethysmography sensors and their potential future applications in health care. Int J Biosens Bioelectron. 2018;4(4):195–202.
    1. Li K.H.C., White F.A., Tipoe T. The current state of mobile phone apps for monitoring heart rate, heart rate variability, and atrial fibrillation: narrative review. JMIR Mhealth Uhealth. 2019;7(2)
    1. Halcox J.P.J., Wareham K., Cardew A. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation. 2017;136(19):1784–1794.
    1. Steinhubl S.R., Waalen J., Edwards A.M. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the MSTOPS randomized clinical trial. JAMA. 2018;320(2):146–155.
    1. Brunetti N.D., De Gennaro L., Pellegrino P.L., Dellegrottaglie G., Antonelli G., Di Biase M. Atrial fibrillation with symptoms other than palpitations: incremental diagnostic sensitivity with at-home tele-cardiology assessment for emergency medical service. Eur J Prev Cardiol. 2012;19(3):306–313.
    1. American College of Cardiology Apple heart study identifies AFib in small group of Apple Watch wearers. Accessed September 12, 2019.
    1. Jencks S.F., Williams M.V., Coleman E.A. Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–1428.
    1. . Heart failure matters.
    1. Seto E., Leonard K.J., Cafazzo J.A., Barnsley J., Masino C., Ross H.J. Mobile phone-based telemonitoring for heart failure management: a randomized controlled trial. J Med Internet Res. 2012;14(1):e31.
    1. Dendale P., De Keulenaer G., Troisfontaines P. Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (telemonitoring in the management of heart failure) study. Eur J Heart Fail. 2012;14(3):333–340.
    1. Chaudhry S.I., Mattera J.A., Curtis J.P. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363(24):2301–2309.
    1. Ledwidge M.T., O'Hanlon R., Lalor L. Can individualized weight monitoring using the heartphone algorithm improve sensitivity for clinical deterioration of heart failure? Eur J Heart Fail. 2013;15(4):447–455.
    1. Anand I.S., Tang W.H., Greenberg B.H. Design and performance of a multisensor heart failure monitoring algorithm: results from the multisensor monitoring in congestive heart failure (music) study. J Card Fail. 2012;18(4):289–295.
    1. Sanchez-Ross M., Oghlakian G., Maher J. The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomes. JACC Cardiovasc Interv. 2011;4(2):222–227.
    1. Johnston N., Bodegard J., Jerstrom S. Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: a randomized study. Am Heart J. 2016;178:85–94.
    1. Chow C.K., Redfern J., Hillis G.S. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314(12):1255–1263.
    1. Tsai L.L., McNamara R.J., Moddel C., Alison J.A., McKenzie D.K., McKeough Z.J. Home-based telerehabilitation via real-time videoconferencing improves endurance exercise capacity in patients with copd: the randomized controlled teler study. Respirology. 2017;22(4):699–707.
    1. Vorrink S.N., Kort H.S., Troosters T., Zanen P., Lammers J.J. Efficacy of an mhealth intervention to stimulate physical activity in COPD patients after pulmonary rehabilitation. Eur Respir J. 2016;48(4):1019–1029.
    1. National Institutes of Health Clinical Center. Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis. NCT03562247. . Bethesda, MD: National Institutes of Health; 2007. . Updated August 6, 2018.
    1. Dalla Vecchia L.A., Bussotti M. Exercise training in pulmonary arterial hypertension. J Thorac Dis. 2018;10(1):508–521.
    1. National Institutes of Health Clinical Center. A Mobile Health Intervention in Pulmonary Arterial Hypertension. NCT03069716. . Bethesda, MD: National Institutes of Health; 2007. . Updated November 14, 2019.
    1. National Institutes of Health Clinical Center. Pulmonary hypertension, hypoxia, and sickle cell disease. NCT03617458. . Bethesda, MD: National Institutes of Health; 2007. . Updated November 20, 2019.
    1. Brooks G.C., Vittinghoff E., Iyer S. Accuracy and usability of a self-administered 6-minute walk test smartphone application. Circ Heart Fail. 2015;8(5):905–913.
    1. Goel K., Lennon R.J., Tilbury R.T., Squires R.W., Thomas R.J. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation. 2011;123(21):2344–2352.
    1. Humen D., Higgins G., Unsworth K., Prior P., Massel D., Suskin N. A cost analysis of event reduction provided by a comprehensive cardiac rehabilitation program. Can J Cardiol. 2013;29(10):S156.
    1. Gomadam P.S., Douglas C.J., Sacrinty M.T., Brady M.M., Paladenech C.C., Robinson K.C. Degree and direction of change of body weight in cardiac rehabilitation and impact on exercise capacity and cardiac risk factors. Am J Cardiol. 2016;117(4):580–584.
    1. Ades P.A., Keteyian S.J., Wright J.S. Increasing cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative. Mayo Clin Proc. 2017;92(2):234–242.
    1. Benjamin E.J., Muntner P., Alonso A. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
    1. Balady G.J., Ades P.A., Bittner V.A. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation. 2011;124(25):2951–2960.
    1. Dunlay S.M., Witt B.J., Allison T.G. Barriers to participation in cardiac rehabilitation. Am Heart J. 2009;158(5):852–859.
    1. Varnfield M., Karunanithi M., Lee C.K. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart. 2014;100(22):1770–1779.
    1. Whittaker F., Wade V. The costs and benefits of technology-enabled, home-based cardiac rehabilitation measured in a randomised controlled trial. J Telemed Telecare. 2014;20(7):419–422.
    1. Widmer R.J., Allison T.G., Lennon R., Lopez-Jimenez F., Lerman L.O., Lerman A. Digital health intervention during cardiac rehabilitation: a randomized controlled trial. Am Heart J. 2017;188:65–72.
    1. Swarup S., Makaryus A.N. Digital stethoscope: technology update. Med Devices (Auckl) 2018;11:29–36.
    1. Becker C., Fusaro M., Patel D., Shalom I., Frishman W.H., Scurlock C. The utility of teleultrasound to guide acute patient management. Cardiol Rev. 2017;25(3):97–101.
    1. Downey C., Randell R., Brown J., Jayne D.G. Continuous versus intermittent vital signs monitoring using a wearable, wireless patch in patients admitted to surgical wards: pilot cluster randomized controlled trial. J Med Internet Res. 2018;20(12)
    1. Weenk M., Koeneman M., van de Belt T.H., Engelen L., van Goor H., Bredie S.J.H. Wireless and continuous monitoring of vital signs in patients at the general ward. Resuscitation. 2019;136:47–53.
    1. Izmailova E.S., Wagner J.A., Perakslis E.D. Wearable devices in clinical trials: hype and hypothesis. Clin Pharmacol Ther. 2018;104(1):42–52.
    1. Avram R., Tison G.H., Aschbacher K. Real-world heart rate norms in the health eheart study. NPJ Digit Med. 2019;2:58.
    1. McConnell M.V., Shcherbina A., Pavlovic A. Feasibility of obtaining measures of lifestyle from a smartphone app: the MyHeart counts cardiovascular health study. JAMA Cardiol. 2017;2(1):67–76.
    1. McLean A. Apple researchkit and carekit. Can J Nurs Inform. 2019;14(1)
    1. Urban JM, Hoofnagle CJ, Li S. Mobile phones and privacy. CLT Research Paper Series; UC Berkeley Public Law Research Paper No. 2103405.
    1. Grundy Q., Chiu K., Held F., Continella A., Bero L., Holz R. Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis. BMJ. 2019;364:I920.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe